Effect of Selenium on Succinylcholine-Induced POM
NCT03476044 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 80
Last updated 2020-10-19
Summary
For more than 60 years, succinylcholine is still being administered as the selective relaxant for rapid sequence intubation by anesthesiologists in many countries. It has been shown to possess unique features such as low cost, fast-acting, short half-life, safe metabolites, and causing excellent muscle relaxation for intubation. However, it has many side effects as well.
Postoperative myalgia (POM), with an incidence rate of about 41%-92%, is one of the most common side effects of this drug and can take several days to cause significant discomfort in patients. However, its effect is felt more in the throat, neck, shoulder, and abdominal muscles and is common among patients with outpatient surgery. Due to its unknown real context of pathogenesis and in an effort to reduce the incidence and severity of succinylcholine-induced myalgia, various medications including non-depolarizing muscle relaxants, benzodiazepines, magnesium sulfate, opioids, gabapentin, pregabalin and nonsteroidal anti-inflammatory drugs have been tested, with varying degrees of success.
Free radicals are created as a consequence of ATP (adenosine triphosphate) production by the mitochondria. These by-products are generally reactive oxygen species (ROS) as well as reactive nitrogen species (RNS) that result from the cellular redox process. These species play a dual role as both toxic and beneficial compounds. The delicate balance between their two antagonistic effects is clearly an important aspect of life. At low or moderate levels, ROS and RNS exert beneficial effects on cellular responses and immune function. At high concentrations, they generate oxidative stress, a deleterious process that can damage all cell structures. Muscle injuries might lead to the production of free radicals and further cellular damage, triggered by lipid peroxidation and protein oxidation. Peroxidation of membrane lipids leads to loss of membrane fluidity and elasticity, impaired cellular functioning, and even cell rupture. The various direct products of lipid peroxidation, such as malondialdehyde (MDA), isoprostanes, and 4-hydroxynonenal are considered among the most important biomarkers of oxidative stress in tissues. Malondialdehyde is a reactive carbonyl compound and is both mutagenic and carcinogenic. It reacts with DNA to form DNA adducts that are believed to contribute significantly to cancers linked to lifestyle and dietary factors. Protein oxidation can cause fragmentation at amino acid residues, formation of protein-protein cross-linkages, and oxidation of the protein backbone which ultimately leads to loss of function. Damaged proteins affect intracellular pathways and are contributing factors to different disorders and diseases. Protein carbonyl (CO) groups are produced on protein side chains during oxidation. High levels of protein CO groups have been observed in rheumatoid arthritis, Alzheimer's disease, diabetes, sepsis and chronic renal failure.
Selenium is a well-recognized antioxidant which act s as a cofactor of antioxidant enzymes. This essential element helps protect the body against free radicals causing damage to the cells. Substantial evidence suggests that free radical production leads to increased oxygen uptake over time. The indirect though significant impact of selenium supplements is to protect the cells against oxidative stress and free radical production. Nature-made selenium contains 200 mg of this element with a natural origin, high absorption capacity, and prolonged retention. Selenium exerts its antioxidant effects through glutathione peroxidase. Glutathione peroxidase is an enzyme containing four selenium-cofactors that catalyze the breakdown of hydrogen peroxide and organic hydroperoxides. There are at least four different glutathione peroxidase isozymes in animals. Glutathione peroxidase 1 is the most abundant and is a very efficient scavenger of hydrogen peroxide, while glutathione peroxidase 4 is most active with lipid hydroperoxides. The glutathione S-transferases show high activity with lipid peroxides. These enzymes are at particularly high levels in the liver and serve in detoxification metabolism.
Conditions
- Postoperative Myalgia
Interventions
- DRUG
-
40 patients will receive starch capsules orally with sips of water 2 hours before induction of anesthesia
- DRUG
-
Selenium
40 patients will receive Selenium (selenium NATURE'S BOUNTY, INC. Bohemia) 200 mcg orally with sips of water 2 hours before induction of general anesthesia
Sponsors & Collaborators
-
Assiut University
lead OTHER
Principal Investigators
-
Ekram A Osman, MD · Assiut University, Faculty of Medicine
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 20 Years
- Max Age
- 40 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-06-01
- Primary Completion
- 2020-03-31
- Completion
- 2020-03-31
Countries
- Egypt
Study Locations
More Related Trials
-
Sevoflurane Associated With Oral Midazolam and Ketamine for Dental Sedation
NCT02284204 ·Status: COMPLETED ·Phase: PHASE2
-
Comparison on Succinylcholine Onset Time Assessed by Train of Four Stimulation Versus Clinical Judgment During Rapid Sequence Induction of Anesthesia
NCT03415607 ·Status: UNKNOWN
-
Mask Ventilation Before and After Neuromuscular Blockade
NCT02237443 ·Status: COMPLETED ·Phase: PHASE4
-
Intubating Condition After Magnesium Pre-treatment
NCT01153256 ·Status: COMPLETED ·Phase: NA
-
Three Different Doses of Neostigmine on the Reversal of Cisatracurium-induced Moderate Neuromuscular Blockade
NCT05037006 ·Status: UNKNOWN ·Phase: PHASE4
-
Small Doses Muscle Relaxant in General Anesthesia
NCT04344262 ·Status: RECRUITING ·Phase: NA
-
Magnesium Sulphate and Sevoflurane Induced Emergence Agitation in Children
NCT01743144 ·Status: UNKNOWN ·Phase: PHASE4
-
Influence of the Neuromuscular Blockade on Mask Ventilation
NCT02318810 ·Status: COMPLETED ·Phase: NA
-
Evaluate the Muscle Protection Effect of Sevoflurane Sedation in Vascular Surgery
NCT03215446 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of Rocuronium and Sugammadex Under Sevoflurane and Desflurane Anesthesia in Children
NCT03795259 ·Status: COMPLETED ·Phase: NA
-
Effects of Sevoflurane in Subanesthetic Concentrations on the Forearm Perfusion
NCT00526695 ·Status: UNKNOWN ·Phase: PHASE4
-
Emergence Agitation of Sevoflurane in Pediatric
NCT06830564 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
WashIn /WashOut Procedure To Prevent Agitation During Recovery After Inhalational Anesthesia With Sevoflurane
NCT04765488 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Aminophylline and Cognitive Function After Sevoflurane Anaesthesia
NCT01022151 ·Status: COMPLETED ·Phase: PHASE2
-
Sevoflurane Sedation as an Alternative for Awake Fiberoptic Intubation in Difficult Airway Patients
NCT06601036 ·Status: RECRUITING ·Phase: NA
-
Postoperative Effects of Propofol Versus Sevoflurane Anesthesia
NCT05935930 ·Status: COMPLETED ·Phase: PHASE4
-
Caudal Versus Intravenous Magnesium Sulfate on Emergence Agitation After Sevoflurane In Children.
NCT03846284 ·Status: UNKNOWN ·Phase: NA
-
Effects of Sedatives on Sublingual Microcirculation of Patients With Septic Shock
NCT01618396 ·Status: COMPLETED ·Phase: NA
-
The Effect of Sevoflurane on Cerebral CO2 Sensitivity and Systemic Arteries
NCT02054143 ·Status: COMPLETED ·Phase: PHASE4
-
Effects of Sevoflurane Versus Desflurane Anesthesia Under Protective Mechanical Ventilation for Robotic Assisted Surgery
NCT07304479 ·Status: RECRUITING ·Phase: NA
-
Effect of Inhalation Sedation Compared With Propofol on the Sepsis-related Acute Respiratory Distress Syndrome Course
NCT04014218 ·Status: UNKNOWN ·Phase: PHASE4
-
Residual Neuromuscular Block of Rocuronium in Chemotherapy Patients Under Sevoflurane Anesthesia
NCT04965532 ·Status: UNKNOWN ·Phase: NA
-
Effect of Sugammadex vs. Neostigmine/Glycopyrrolate on Pediatric Emergence Delirium in Sevoflurane-rocuronium Anesthesia
NCT03229486 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of Sevoflurane, Propofol and Dexmedetomidine on Delirium & Neuroinflammation in Mechanically Ventilated Patients
NCT02394418 ·Status: WITHDRAWN ·Phase: PHASE4
-
Effects of Subanesthetic Isoflurane/Sevoflurane in 60% Oxygen on Clinical In-vitro Experimental Sepsis
NCT02185118 ·Status: UNKNOWN ·Phase: NA